Integrated BioPharma, Inc. (INBP)
OTCMKTS: INBP · Delayed Price · USD
+0.003 (1.38%)
May 14, 2024, 1:46 PM EDT - Market closed

Integrated BioPharma Statistics

Total Valuation

INBP has a market cap or net worth of $6.62 million. The enterprise value is $6.64 million.

Market Cap 6.62M
Enterprise Value 6.64M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

INBP has 30.10 million shares outstanding. The number of shares has increased by 2.72% in one year.

Shares Outstanding 30.10M
Shares Change (YoY) +2.72%
Shares Change (QoQ) +2.21%
Owned by Insiders (%) 79.76%
Owned by Institutions (%) 0.07%
Float 22.17M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.11
Forward PS n/a
PB Ratio 0.35
P/FCF Ratio 70.88
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.37, with an EV/FCF ratio of 71.08.

EV / Earnings n/a
EV / Sales 0.11
EV / EBITDA 12.37
EV / EBIT n/a
EV / FCF 71.08

Financial Position

The company has a current ratio of 2.63, with a Debt / Equity ratio of 0.11.

Current Ratio 2.63
Quick Ratio 0.97
Debt / Equity 0.11
Debt / EBITDA 3.80
Debt / FCF 21.83
Interest Coverage 2.47

Financial Efficiency

Return on equity (ROE) is -0.61% and return on invested capital (ROIC) is -0.34%.

Return on Equity (ROE) -0.61%
Return on Assets (ROA) -0.43%
Return on Capital (ROIC) -0.34%
Revenue Per Employee $444,312
Profits Per Employee -$823
Employee Count 141
Asset Turnover 2.38
Inventory Turnover 5.60


In the past 12 months, INBP has paid $53,000 in taxes.

Income Tax 53,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -42.09% in the last 52 weeks. The beta is 0.52, so INBP's price volatility has been lower than the market average.

Beta (1Y) 0.52
52-Week Price Change -42.09%
50-Day Moving Average 0.22
200-Day Moving Average 0.25
Relative Strength Index (RSI) 57.49
Average Volume (30 Days) 1,379

Short Selling Information

Short Interest n/a
Short Previous Month 11,751
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, INBP had revenue of $62.65 million and -$116,000 in losses. Loss per share was -$0.00.

Revenue 62.65M
Gross Profit 3.59M
Operating Income -72,000
Pretax Income -63,000
Net Income -116,000
EBITDA 537,000
EBIT -66,600
Loss Per Share -$0.00
Full Income Statement

Balance Sheet

The company has $2.02 million in cash and $2.04 million in debt, giving a net cash position of -$19,000 or -$0.00 per share.

Cash & Cash Equivalents 2.02M
Total Debt 2.04M
Net Cash -19,000
Net Cash Per Share -$0.00
Equity / Book Value 18.91M
Book Value Per Share 0.63
Working Capital 11.32M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $456,486 and capital expenditures -$363,062, giving a free cash flow of $93,424.

Operating Cash Flow 456,486
Capital Expenditures -363,062
Free Cash Flow 93,424
FCF Per Share $0.00
Full Cash Flow Statement


Gross margin is 5.72%, with operating and profit margins of -0.11% and -0.19%.

Gross Margin 5.72%
Operating Margin -0.11%
Pretax Margin -0.10%
Profit Margin -0.19%
EBITDA Margin 0.86%
EBIT Margin -0.11%
FCF Margin 0.15%

Dividends & Yields

INBP does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth 1
Payout Ratio n/a
Buyback Yield -2.72%
Shareholder Yield -2.72%
Earnings Yield -1.75%
FCF Yield 1.41%
Dividend Details

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a


INBP has an Altman Z-Score of 1.63 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.63
Piotroski F-Score 4